Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01697332 · ClinicalTrials.gov registry record · Phase 1
Functional Applications of Hyperpolarized 129Xe MRI
A Phase 1 study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01697332 is a Phase 1 study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 1 participants.
The verdict
NCT01697332, a Phase 1 study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The overall objectives of our study are to determine the capabilities of hyperpolarized 129Xe MRI to measure lung function and its potential to sensitively detect pulmonary disease and its progression in COPD. We hypothesize that measurement of alveolar surface area, septal thickness, and capillary transit time measured with hyperpolarized 129Xe will correlate better with quality of life measures in COPD subjects than traditional diagnostic measures such as spirometry and Computed Tomography.
Interventions
- DRUG Hyperpolarized 129Xe gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01697332
The ClinicalTrials.gov registry entry for NCT01697332 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized 129Xe gas is the first listed.
NCT01697332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01697332 about?
NCT01697332 is a clinical study titled "Functional Applications of Hyperpolarized 129Xe MRI". The overall objectives of our study are to determine the capabilities of hyperpolarized 129Xe MRI to measure lung function and its potential to sensitively detect pulmonary disease and its progression in COPD. We hypothesize that measurement of alveolar surface area, septal thickness, and capillary ...
What is the current status of trial NCT01697332?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2013-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01697332?
The interventions under investigation include: Hyperpolarized 129Xe gas (DRUG).
Who is sponsoring clinical trial NCT01697332?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.